US Reliance On EU Drug Facility Inspections Begins In November
Executive Summary
FDA will have completed capability assessments for eight European Union member country inspectorates by that time, with all 28 to be completed by mid-2019; EU assessment of US regulator’s inspection capabilities wraps up in July.
You may also be interested in...
Before The Freeze: US FDA Inspection Data Pointed To Continued Foreign Facility Focus
Until the coronavirus forced it to stop, the FDA had planned to up domestic and foreign inspections in FY 2020 and FY 2021, as the longer-term trend showed domestic inspections dropping and foreign inspections rising.
Mutual Recognition's Next Evolution May Be Sharing Info On India And China Inspections
Now that US FDA has approved the final EU authority, mutual recognition efforts could expand and deepen. Former FDA chief counsel Rebecca Wood discusses the future of approval standards harmonization in Pink Sheet interview.
USMCA Trade Negotiations: Could US House Dems' Talks Open Door For AAM Changes?
Biologics exclusivity remains a contentious issue as US Trade Representative and House Democrats begin discussions on the trade pact with Mexico and Canada.